Wall Street Experts
ver. ZuMIgo(08/25)
Protalix BioTherapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 46
EBIT TTM (mln): -8
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
8 |
34 |
12 |
15 |
4 |
9 |
19 |
34 |
55 |
63 |
38 |
48 |
65 |
Przychód Δ r/r |
0.0% |
-100.0% |
-100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
-100.0% |
0.0% |
inf% |
1611.9% |
26.3% |
310.5% |
-66.6% |
31.7% |
-71.2% |
110.8% |
109.2% |
77.9% |
59.7% |
15.0% |
-39.0% |
24.2% |
37.5% |
Marża brutto |
24.5% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
76.7% |
0.0% |
0.0% |
-821.4% |
-35.3% |
17.2% |
76.3% |
52.9% |
40.3% |
83.3% |
8.7% |
20.8% |
72.8% |
80.1% |
82.7% |
57.4% |
58.9% |
64.9% |
EBIT (mln) |
-1 |
-0 |
-0 |
-0 |
-0 |
-0 |
-0 |
-10 |
-25 |
-24 |
-32 |
-30 |
-37 |
-12 |
-27 |
-25 |
-24 |
-33 |
-36 |
-19 |
-11 |
2 |
-20 |
-13 |
10 |
EBIT Δ r/r |
0.0% |
-53.2% |
1.0% |
-57.0% |
-11.1% |
12.3% |
-43.7% |
10373.2% |
151.4% |
-1.6% |
32.3% |
-6.3% |
21.9% |
-66.7% |
122.8% |
-7.1% |
-6.1% |
40.1% |
9.6% |
-46.9% |
-44.5% |
-117.2% |
-1208.5% |
-36.4% |
-180.4% |
EBIT (%) |
-23.0% |
-38185100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-6514.0% |
0.0% |
0.0% |
-8239.4% |
-451.2% |
-435.6% |
-35.4% |
-235.5% |
-166.3% |
-542.4% |
-360.5% |
-188.9% |
-56.4% |
-19.6% |
2.9% |
-53.4% |
-27.3% |
16.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
-1 |
5 |
4 |
11 |
10 |
8 |
8 |
10 |
8 |
3 |
3 |
EBITDA (mln) |
-0 |
-1 |
-0 |
-0 |
-0 |
-0 |
-0 |
-9 |
-24 |
-23 |
-30 |
-36 |
-33 |
-8 |
-24 |
-25 |
-24 |
-31 |
-36 |
-19 |
-9 |
3 |
-20 |
-11 |
12 |
EBITDA(%) |
-11.2% |
-53208100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-6179.3% |
0.0% |
0.0% |
-7726.5% |
-542.6% |
-392.3% |
-24.6% |
-204.8% |
-165.0% |
-539.6% |
-332.5% |
-187.9% |
-54.8% |
-15.9% |
5.0% |
-52.3% |
-22.6% |
17.8% |
Podatek (mln) |
0 |
-0 |
-0 |
-0 |
0 |
0 |
-0 |
11 |
-2 |
45 |
63 |
49 |
43 |
0 |
0 |
-3 |
-88 |
11 |
8 |
1 |
8 |
8 |
6 |
1 |
0 |
Zysk Netto (mln) |
-1 |
-0 |
-0 |
-0 |
-0 |
-0 |
-0 |
-9 |
-22 |
-22 |
-31 |
-29 |
-37 |
-12 |
-28 |
-30 |
58 |
-29 |
-85 |
-26 |
-26 |
-15 |
-34 |
-15 |
8 |
Zysk netto Δ r/r |
0.0% |
-89.4% |
211.7% |
-54.5% |
-6.0% |
13.8% |
-53.2% |
12431.5% |
139.4% |
-0.3% |
40.3% |
-7.8% |
26.0% |
-68.2% |
139.2% |
7.7% |
-293.8% |
-150.6% |
190.4% |
-69.0% |
-0.8% |
-43.3% |
128.2% |
-56.1% |
-155.7% |
Zysk netto (%) |
-28.1% |
-10560900.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-6260.0% |
0.0% |
0.0% |
-8103.1% |
-436.6% |
-435.6% |
-33.7% |
-241.4% |
-197.5% |
1329.9% |
-319.2% |
-443.2% |
-77.3% |
-48.0% |
-23.7% |
-88.6% |
-31.3% |
12.7% |
EPS |
-1.91 |
-0.26 |
-1.02 |
-0.51 |
-0.48 |
-0.0085 |
-0.004 |
-0.32 |
-3.35 |
-0.3 |
-0.41 |
-0.36 |
-0.43 |
-0.13 |
-0.3 |
-0.32 |
0.61 |
-0.29 |
-6.51 |
-1.8 |
-1.77 |
-0.51 |
-0.77 |
-0.31 |
0.12 |
EPS (rozwodnione) |
-1.91 |
-0.26 |
-1.02 |
-0.51 |
-0.48 |
-0.0085 |
-0.004 |
-0.32 |
-3.35 |
-0.3 |
-0.41 |
-0.36 |
-0.43 |
-0.13 |
-0.3 |
-0.32 |
0.61 |
-0.29 |
-6.51 |
-1.8 |
-1.77 |
-0.51 |
-0.77 |
-0.31 |
0.0867 |
Ilośc akcji (mln) |
1 |
0 |
0 |
0 |
0 |
19 |
19 |
29 |
7 |
76 |
77 |
81 |
85 |
91 |
92 |
93 |
95 |
101 |
13 |
15 |
15 |
29 |
44 |
48 |
68 |
Ważona ilośc akcji (mln) |
1 |
0 |
0 |
0 |
0 |
19 |
19 |
29 |
7 |
76 |
77 |
81 |
85 |
91 |
92 |
93 |
95 |
101 |
13 |
15 |
15 |
29 |
44 |
48 |
82 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |